BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 28, 2026; 32(40): 116827
Published online Oct 28, 2026. doi: 10.3748/wjg.116827
Table 1 Characteristics and outcome of the patients with anal fistulas, mean ± SD/n (%)
Variables
Perianal fistula in CD (n = 69)
Cryptoglandular anal fistula (n = 182)
P value
Age26.03 ± 7.7542.70 ± 12.08< 0.001
Male/female50/19158/240.007
Duration of anal fistula (month)14.61 ± 22.0925.51 ± 49.73< 0.001
Duration of CD (month)8.87 ± 18.29--
Previous fistula surgery32 (46.4)94 (51.6)> 0.05
Biological agents (such as anti-tumor necrosis factor)24 (34.8)--
magnetic resonance imaging feature
Neither transmural inflammation nor active proctitis12 (17.4)147 (80.7)< 0.001
Only transmural inflammation11 (15.9)16 (8.8)< 0.001
Only active proctitis25 (36.2)16 (8.8)< 0.001
Transmural inflammation and active proctitis21 (30.4)3 (1.6)< 0.001


Write to the Help Desk